This is a preview of subscription content, log in via an institution to check access.
Notes
prostate-specific antigen
Another study has suggested that a personalised approach to prostate cancer screening may have potential to save the UK NHS millions of pounds. see PharmacoEconomics & Outcomes News 667 p11; 801085585
Reference
Martin AJ, et al. Risk assessment to guide prostate cancer screening decisions: a cost-effectiveness analysis. Medical Journal of Australia 198: 546-50, No. 10, Jan 2013. Available from: URL: http://dx.doi.org/10.5694/mja12.11597
Rights and permissions
About this article
Cite this article
Prostate cancer screening worthwhile in some. PharmacoEcon Outcomes News 681, 10 (2013). https://doi.org/10.1007/s40274-013-0520-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0520-5